# DESCRIPTION

## TECHNICAL FIELD OF THE INVENTION

- define technical field

## BACKGROUND OF THE INVENTION

- motivate need for invention

## SUMMARY OF THE INVENTION

- introduce TFPI-binding peptides
- define peptide structure with variable amino acids
- provide specific peptide sequences
- describe cyclic structure of peptides
- introduce formula (III) peptide structure
- introduce formula (V) peptide structure with optional amino acids
- summarize additional peptide structures and formulas
- define TFPI-binding peptides
- describe peptide structures and variations
- outline methods of using peptides
- describe compositions and pharmaceutical uses
- outline methods of identifying TFPI-binding compounds
- describe computer-implemented methods
- provide numbered paragraphs defining exemplary variations of the invention
- define TFPI-binding peptides
- describe therapeutic methods using TFPI-binding peptides
- describe diagnostic methods using TFPI-binding peptides
- describe purification methods using TFPI-binding peptides
- describe methods for identifying TFPI-binding compounds
- describe methods for detecting TFPI-binding compounds
- describe computer-aided methods for modeling TFPI-binding compounds
- describe computer-aided methods for comparing TFPI-binding compounds

## DETAILED DESCRIPTION OF THE INVENTION

- introduce TFPI and its role in blood coagulation cascade
- describe peptide structures and conventions for amino acid sequences
- provide specific examples of TFPI-binding peptides and their variations
- define peptide structure
- specify amino acid sequences
- provide examples of peptide structures
- describe variations of peptide structures
- summarize peptide structures with alternative amino acid residues
- define peptide structures
- describe N-terminal and C-terminal additions
- introduce cyclic structures and disulfide bonds
- specify TFPI-binding peptide structures
- define peptide structure
- specify amino acid options
- provide sequence identity requirements
- describe TFPI-binding peptide variants
- define amino acid sequences
- specify peptide structure
- describe peptide composition
- provide peptide formula
- define TFPI-binding peptides
- describe amino acid sequences
- specify structure of formula (XI)
- exclude structure of formula (XII)
- describe N-terminal and C-terminal modifications
- specify cyclic structures
- provide examples of peptides
- define amino acid substitutions
- describe TFPI-inhibitory peptide variants
- outline fusion proteins and peptides
- detail derivatives of TFPI-inhibitory peptides
- describe chemical modifications of peptides
- summarize peptide derivatives with modified amino acids
- define retro-modified peptides
- describe synthesis of TFPI-binding peptides
- outline preparation of nucleic acids encoding TFPI-inhibitory peptides
- describe formulation of TFPI-inhibitory peptides in compositions
- propose mechanism of inhibition of TFPI activity
- describe characterization of TFPI-inhibitory activity in model systems
- outline methods for determining affinity and specificity of TFPI-binding peptides
- describe TFPI-inhibitory peptides
- methods of detecting and/or quantifying TFPI
- methods of targeting biological structures with TFPI-binding peptides
- detecting peptide-TFPI complexes
- methods of diagnosing and treating diseases associated with TFPI activity
- methods of purifying TFPI and enhancing thrombin formation
- define blood coagulation disorders
- describe coagulation disorders caused by deficient blood coagulation factor activity
- describe coagulation disorders caused by deficient platelet activity
- describe treatment of blood coagulation disorders using TFPI-inhibitory peptides
- describe use of TFPI-inhibitory peptides to reverse effects of anticoagulants
- describe administration regimens for TFPI-inhibitory peptides
- describe dosage and conditions of administration for TFPI-inhibitory peptides
- describe methods of administering TFPI-inhibitory peptides
- describe co-treatment with other substances and therapeutic modalities
- describe TFPI-binding compounds
- motivate method for identifying TFPI-binding compounds
- describe method for identifying TFPI-binding compounds using KD1-TFPI-binding peptide complexes
- describe method for identifying TFPI-binding compounds using KD1-FXa binding
- describe method for identifying TFPI-binding compounds using TFPI binding site defined by KD1 amino acid residues
- describe detection methods for binding of test compound to TFPI binding site
- describe indirect detection of binding of test compound to TFPI binding site
- describe use of NMR to detect binding of test compound to TFPI binding site
- describe enzymatic assays for evaluating FVIIa or FXa activity
- describe computer storage media and methods for modeling candidate TFPI-compounds in TFPI binding site
- describe computer storage media and methods for comparing test compounds to selected three dimensional points in TFPI KD1 protein
- describe computer hardware components
- illustrate storage of computer readable instructions
- introduce TFPI protein and its structure
- describe method of performing KD1 and peptide interaction modeling
- detail steps of 3D modeling and fitting of peptide to KD1 surface
- discuss affinity rating calculation and iteration of peptide analysis

### EXAMPLES

- introduce example 1
- describe peptide synthesis and identification
- detail microarray-based scan analysis
- perform ELISA-like assay for peptide binding
- introduce example 2
- analyze peptide binding to TFPI-1 and TFPI-2
- describe extrinsic tenase inhibition assay
- describe FXa inhibition assay
- present results of TFPI inhibitory activity of peptides
- describe plasma-based assay for thrombin generation
- describe modification of peptides to enhance physicochemical or pharmacokinetic properties
- characterize peptides in assays
- describe cell-based extrinsic tenase assay
- illustrate peptide activity in animal model
- describe NMR sample preparation
- analyze NMR spectra of TFPI160-JBT0303 complex
- identify binding site of JBT0303 on TFPI160
- describe NMR sample preparation of TFPI160-JBT0122 complex
- analyze NMR spectra of TFPI160-JBT0122 complex
- identify residues of JBT0122 that interact with TFPI160
- determine secondary structure of JBT0122
- identify residues of JBT0303 that interact with TFPI160
- determine secondary structure of JBT0616
- analyze NMR spectra of JBT0616 in complex with TFPI160
- create model of KD1-JBT0303 complex using HADDOCK software
- model JBT0740 and JBT1857 bound to KD1
- determine X-ray crystal structure of JBT1857 bound to KD1
- describe interaction of JBT1857 and KD1
- describe PEGylated peptides
- assess stability and TFPI-inhibitory activity
- perform rotational thromboelastography
- conduct nail clip study
- summarize results and demonstrate TFPI-binding peptide activity
- describe TFPI-binding peptides
- compare affinity and TFPI-inhibitory activity of JBT1837 and JBT1857
- illustrate in vivo activity of TFPI-binding peptides in a clinically-relevant animal model
- describe method for detecting TFPI using inventive peptides in an ELISA-like assay format
- describe conditions for an exemplary koff assay for characterizing TFPI-binding peptides
- evaluate influence of TFPI-binding peptides on TFPI's inhibition of FVIIa/TF
- describe influence of PEG and HSA conjugation on exemplary TFPI-binding peptides in vivo
- illustrate pharmacokinetic profile of JBT2401, JBT2404, and JBT2410
- summarize results of in vivo experiments

